Filing Flows › Twist Bioscience (TWST) › Next earnings date
Twist Bioscience (TWST) earnings on Nov 12, 2026: what to expect
Twist Bioscience (TWST) is expected to report earnings on Nov 12, 2026, in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.20 (−$0.38 to −$0.02, 4 estimates) on revenue of $124M, against −$0.45 and $99.0M a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 58% chance of beating next time.
What to watch
Last quarter (Q3 FY26) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.45 on revenue of $123M, against the analysts' −$0.20.
The last report
Twist Bioscience reported revenue of $118M for the third quarter fiscal 2026 (+23% Y/Y), net loss $35.1M: NGS applications $61.8M, DNA synthesis and protein solutions $56.6M. How it makes money → · Every quarter →
Twist Bioscience's latest quarter
Twist Bioscience, Q3 FY26: revenue $118M (+23% year over year), operating margin -30.6%, net loss $35.1M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Questions
When does TWST report earnings?
Twist Bioscience is expected to report on Nov 12, 2026.
What are analysts expecting from Twist Bioscience?
EPS of −$0.20 and revenue of $124M for the quarter.
Does Twist Bioscience usually beat earnings?
It beat the consensus EPS estimate in 50% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.